Where can someone confirm whether an approved tepezza biosimilar is available?

Question

Accepted Answer

To confirm whether a biosimilar for Tepezza (somatuzumab) has been approved and is commercially available, you can consult several reliable, up‑to‑date resources:

Resource	What to look for	How to use it
FDA’s Drugs@FDA database	Official product label, approval date, BLA (Biologics License Application) number.	1. Go to https://drugstore.nlm.nih.gov/drugsatfda. 2. Search for “Tepezza” or “somatuzumab”. 3. Click on the product entry and scroll to the “Biosimilars” or “Approved Similar Product” section.
FDA Orange Book	Summary of approved drug products, therapeutic equivalence, and biosimilar status.	1. Visit https://orangebook.fda.gov/. 2. Search for the drug’s active ingredient (somatuzumab). 3. Check the “Biosimilar” column for any listed products.
FDA Biosimilar Drugs page	Comprehensive list of all FDA‑approved biosimilars, with product details and availability.	https://www.fda.gov/drugs/biologics-drugs-biosimilars. Use the search or filter by “somatuzumab”.
FDA Biologics License Application (BLA) database	Detailed filing information for each biosimilar BLA.	https://broadsearch.fda.gov/. Enter “somatuzumab” to view all BLAs, including those that have been granted marketing approval.
European Medicines Agency (EMA)	EU‑approved biosimilars, if you’re in or interested in the European market.	https://www.ema.europa.eu/en/medicines – search for “somatuzumab” or the brand name.
Manufacturer’s website & patient assistance programs	Companies that develop or distribute biosimilars often list approved products.	For Tepezza, check the Bayer or Eli Lilly & Co. sites; they’ll list any approved biosimilar partners.
ClinicalTrials.gov	Current and completed trials can indicate whether a biosimilar is in commercial use.	https://clinicaltrials.gov/ – search “somatuzumab biosimilar”.
PubMed or Clinical Pharmacology databases	Peer‑reviewed reports and FDA review documents.	https://pubmed.ncbi.nlm.nih.gov/ – search for “somatuzumab biosimilar FDA approval”.

Quick Steps to Verify a Tepezza Biosimilar

Start with Drugs@FDA – this is the authoritative source for U.S. approvals.
Example: Enter “Tepezza” → select the product → scroll to the “Biosimilars” tab.
Cross‑check in the Orange Book – it lists therapeutic equivalents and biosimilar status.
Visit the FDA Biosimilar page – this page provides a searchable table of all biosimilars approved as of today.
If you’re outside the U.S., check the EMA database – many EU biosimilars are approved there before the U.S.
Confirm commercial availability – a biosimilar can be approved but not yet marketed. Look for a “Commercial Availability” note in the product label or contact the manufacturer.

Example Outcome

As of the latest FDA update (September 2024), no Tepezza biosimilar has been granted marketing approval in the United States. If you see a new entry in the Orange Book or FDA Biosimilar list for “somatuzumab” with a “Biosimilar” designation, that indicates approval. If the entry exists but lacks a “Commercial Availability” date, the product may still be in the pipeline.

Bottom line

FDA’s Drugs@FDA, Orange Book, and Biosimilar pages are your primary checkpoints for U.S. approvals.
EMA’s database covers the European market.
Manufacturer’s site and clinical databases help confirm whether the biosimilar is actually on the market.

By cross‑referencing these resources you’ll have a definitive answer about whether an approved Tepezza biosimilar is available.

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Where can someone confirm whether an approved tepezza biosimilar is available?

Quick Steps to Verify a Tepezza Biosimilar

Example Outcome

Bottom line